95 related articles for article (PubMed ID: 9101815)
1. [Use of recombinant erythropoietin in surgery--are the costs justified?].
Wolff M; Fandrey J; Jelkmann W; Hirner A
Langenbecks Arch Chir Suppl Kongressbd; 1996; 113():143-5. PubMed ID: 9101815
[TBL] [Abstract][Full Text] [Related]
2. [Autologous blood donation versus homologous blood transfusion--an analysis of cost effectiveness].
Dietrich GV
Zentralbl Chir; 1996; 121(10):841-6. PubMed ID: 9019932
[TBL] [Abstract][Full Text] [Related]
3. Preoperative use of recombinant human erythropoietin in pediatric orthopedics: a decision model for long-term outcomes.
Vitale MG; Roye BD; Ruchelsman DE; Roye DP
Spine J; 2007; 7(3):292-300. PubMed ID: 17482112
[TBL] [Abstract][Full Text] [Related]
4. [Cost analysis of autologous transfusion methods--a study of 5,017 patients].
Singbartl G; Schleinzer W
Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Jun; 34(6):350-8. PubMed ID: 10429773
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of the cost of autologous erythrocyte concentrates in a hospital].
Gouëzec H; Tardivel R; Danic B; Ballay JL; Malledant Y
Cah Anesthesiol; 1996; 44(5):451-4. PubMed ID: 9183429
[TBL] [Abstract][Full Text] [Related]
6. Increased iron absorption during autologous blood donation supported by recombinant human erythropoietin therapy.
Bovy C; Baudoux E; Salmon JP; Beguin Y
Transfusion; 2006 Sep; 46(9):1616-23. PubMed ID: 16965592
[TBL] [Abstract][Full Text] [Related]
7. An economic analysis of costs associated with development of a cell salvage program.
Waters JR; Meier HH; Waters JH
Anesth Analg; 2007 Apr; 104(4):869-75. PubMed ID: 17377098
[TBL] [Abstract][Full Text] [Related]
8. The role of recombinant human erythropoietin in the management of anaemic cancer patients: focus on haematological malignancies.
Osterbor A
Med Oncol; 2000 Nov; 17 Suppl 1():S17-22. PubMed ID: 11188781
[TBL] [Abstract][Full Text] [Related]
9. Preoperative recombinant human erythropoietin injection versus preoperative autologous blood donation in patients undergoing radical retropubic prostatectomy.
Chun TY; Martin S; Lepor H
Urology; 1997 Nov; 50(5):727-32. PubMed ID: 9372883
[TBL] [Abstract][Full Text] [Related]
10. [Erythrocytapheresis a few weeks before surgery: an alternative to erythropoietin treatment in programmed autologous transfusion].
Bernière J; Gerota I
Cah Anesthesiol; 1996; 44(4):303-8. PubMed ID: 9033827
[TBL] [Abstract][Full Text] [Related]
11. [A blood transfusion in Sweden--the societal cost].
Glenngård AH; Persson U
Lakartidningen; 2006 Sep 20-26; 103(38):2752-6. PubMed ID: 17058770
[No Abstract] [Full Text] [Related]
12. IL-6 and IL-8 response to erythropoietin therapy in radical hysterectomy.
Hyllner M; Avall A; Bengtson JP; Bengtsson A
Acta Anaesthesiol Scand; 2005 Jan; 49(1):47-51. PubMed ID: 15675981
[TBL] [Abstract][Full Text] [Related]
13. Minimizing perioperative homologous blood exposure with recombinant human erythropoietin.
Levine EA; Gould SA
Surg Annu; 1993; 25 Pt 1():83-99. PubMed ID: 8416148
[TBL] [Abstract][Full Text] [Related]
14. [Preoperative autologous blood donation].
Osswald PM; Lorentz A
Klin Anasthesiol Intensivther; 1993; 43():124-45. PubMed ID: 8421376
[No Abstract] [Full Text] [Related]
15. [Autologous blood donation with recombinant human erythropoietin prior to elective cardiac surgery in anemic patients].
Kiyama H; Ohshima N; Imazeki T; Yamada T
Kyobu Geka; 1998 Aug; 51(9):741-4. PubMed ID: 9742815
[TBL] [Abstract][Full Text] [Related]
16. [Prevention of neonatal anemia with recombinant human erythropoietin: a cost-benefit analysis].
Schefels J; Merz U; Hörnchen H
Z Geburtshilfe Neonatol; 1999 Dec; 203 Suppl 2():1-5. PubMed ID: 10612190
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
18. Cost-utility analysis of recombinant human erythropoietin in anemic cancer patients induced by chemotherapy in Thailand.
Roungrong J; Teerawattananon Y; Chaikledkaew U
J Med Assoc Thai; 2008 Jun; 91 Suppl 2():S119-25. PubMed ID: 19255987
[TBL] [Abstract][Full Text] [Related]
19. Regarding the article "costs associated with blood transfusion in Sweden - the societal cost of autologous, allogeneic and perioperative RBC transfusion".
Jidell E; Norda R; Berseus O; Swärd-Nilsson AM
Transfus Med; 2006 Apr; 16(2):151-2; author reply 153. PubMed ID: 16623922
[No Abstract] [Full Text] [Related]
20. Effects of recombinant human erythropoietin therapy on blood coagulation and fibrinolysis system.
Kobayashi T; Makuuchi H; Takahashi K; Furuse A; Shibata Y; Tsuno H; Kotsuka Y; Kubota H; Imanaka K; Tsukada T; Nakashima M
Ann Thorac Cardiovasc Surg; 2001 Oct; 7(5):273-7. PubMed ID: 11743853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
